Rossari Biotech Limited (ROSSARI) — Announcement | 24 July 2026
Rossari Biotech reported record Q1 FY27 revenue of Rs 697.2 crore, up 28% YoY, driven by strong B2B demand and international expansion, with EBITDA rising 18.7% to Rs 80.6 crore at 11.6% margin. PAT grew 4.5% to Rs 35.1 crore, supported by portfolio rationalization and capacity utilization improvements. Management highlighted ongoing cost optimization, new high-margin product launches, and strategic CAPEX in Thailand and Saudi Arabia to target 15%+ EBITDA margins within 2-3 years. Export revenue remains stable at 23-25% of total, though freight cost inflation and raw material volatility pose near-term headwinds. The company is exiting low-margin segments and investing in higher-value applications like pharma and personal care to sustain growth momentum.
About Rossari Biotech Limited (ROSSARI)
Chemicals · Chemicals · Listed on NSE
📡 Get AI alerts when ROSSARI files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ROSSARI — Free💡 Ask AI about this filing
📊 More ROSSARI filings
- Announcement — 3 August 2026 Rossari Biotech announced it will participate in a semi-annual investor conference on August 10, 202...
- 🟡 Board Meeting — 20 July 2026 Rossari Biotech held its 17th AGM on July 20, 2026 via video conferencing, where all 8 resolutions w...
- Announcement — 20 July 2026 Rossari Biotech announced that the audio recording of its Q1 FY27 earnings conference call held on J...
- 🟡 Board Meeting — 20 July 2026 Rossari Biotech corrected a typographical error in its July 18 board meeting announcement, changing ...
- 🔴 Financial Results — 19 July 2026 Rossari Biotech reported consolidated revenue of Rs. 697.2 crore for Q1 FY27, up 28% YoY, with EBITD...
🔥 Also filed on 24 July 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when ROSSARI files new disclosures
Track ROSSARI filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ROSSARI — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd